AI assistant
MARLOWE PLC Director's Dealing 2022
7777_dirs_2022-01-26_8b660756-7293-4915-8cd8-a8fe95eda11c.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 7288Z
Marlowe PLC
26 January 2022
26 January 2022
Marlowe plc
("Marlowe", the "Company" or the "Group")
Director/PDMR Shareholding
Marlowe announces that following the acquisition of 20,000 ordinary shares in the Company ("Ordinary Shares") by Alex Dacre, the Company's Chief Executive Officer, on 20 January 2022 at a price of 1,000 pence per Ordinary Share as previously disclosed, Adam Councell, Marlowe's Chief Financial Officer, purchased 5,600 Ordinary Shares at a price of 892 pence per Ordinary Share on 25 January 2022.
As a result, Adam Councell is now interested in 22,138 Ordinary Shares, representing approximately 0.02% of the Company's issued ordinary share capital.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation (596/2014), provides further details.
For further information:
| Marlowe plc | www.marloweplc.com |
| Alex Dacre, Chief Executive | Tel: +44 (0) 203 841 6194 |
| Adam Councell, Chief Financial Officer | [email protected] |
| Julian Wais, Head of Investor Relations | |
| Cenkos Securities plc - Nominated Adviser and Joint Broker | |
| Nicholas Wells | Tel: +44 (0)20 7397 8900 |
| Ben Jeynes | |
| George Lawson | |
| Joh. Berenberg, Gossler & Co. KG, London Branch - Joint Broker | |
| Mark Whitmore Ben Wright Dan Gee-Summons |
Tel: +44 (0)20 3207 7800 |
| FTI Consulting | |
| Nick Hasell | Tel: +44 (0)20 3727 1340 |
| Alex Le May |
About Marlowe plc
Marlowe is a UK leader in business critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on health & safety, compliance software, employment law & HR compliance, fire safety, security, water treatment & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 15% of Britain's commercial premises and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated compliance and safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Adam Councell | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Group Chief Financial Officer | |||
| b) | Initial notification /Amendment | Initial notifications | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Marlowe plc | |||
| b) | LEI | 213800ZWSR4SBOM6B608 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Ordinary shares of 50 pence each | |||
| Identification code | ISIN: GB00BD8SLV43 | ||||
| b) | Nature of the transaction | Grants of conditional awards under Marlowe Enterprise Incentive Plan 2021 | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 892 pence | 5,600 | ||||
| d) | Aggregated information | N/A single transactions | |||
| - Aggregated volume | |||||
| - Price | |||||
| e) | Date of the transaction | 25 January 2022 | |||
| f) | Place of the transaction | AIMX |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFZGZMMVNGZZM